Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of KSP-0243 in Japanese and Caucasian healthy adult males
jRCT2071200087Phase 1Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of KSP-0243, sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Adverse events. Started Jan 2021; status: completed.
02
Drugs
KSP-0243
Beyond the preview
Go deeper on jRCT2071200087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200087.